Literature DB >> 9482913

HFE gene knockout produces mouse model of hereditary hemochromatosis.

X Y Zhou1, S Tomatsu, R E Fleming, S Parkkila, A Waheed, J Jiang, Y Fei, E M Brunt, D A Ruddy, C E Prass, R C Schatzman, R O'Neill, R S Britton, B R Bacon, W S Sly.   

Abstract

Hereditary hemochromatosis (HH) is a common autosomal recessive disease characterized by increased iron absorption and progressive iron storage that results in damage to major organs in the body. Recently, a candidate gene for HH called HFE encoding a major histocompatibility complex class I-like protein was identified by positional cloning. Nearly 90% of Caucasian HH patients have been found to be homozygous for the same mutation (C282Y) in the HFE gene. To test the hypothesis that the HFE gene is involved in regulation of iron homeostasis, we studied the effects of a targeted disruption of the murine homologue of the HFE gene. The HFE-deficient mice showed profound differences in parameters of iron homeostasis. Even on a standard diet, by 10 weeks of age, fasting transferrin saturation was significantly elevated compared with normal littermates (96 +/- 5% vs. 77 +/- 3%, P < 0.007), and hepatic iron concentration was 8-fold higher than that of wild-type littermates (2,071 +/- 450 vs. 255 +/- 23 microg/g dry wt, P < 0.002). Stainable hepatic iron in the HFE mutant mice was predominantly in hepatocytes in a periportal distribution. Iron concentrations in spleen, heart, and kidney were not significantly different. Erythroid parameters were normal, indicating that the anemia did not contribute to the increased iron storage. This study shows that the HFE protein is involved in the regulation of iron homeostasis and that mutations in this gene are responsible for HH. The knockout mouse model of HH will facilitate investigation into the pathogenesis of increased iron accumulation in HH and provide opportunities to evaluate therapeutic strategies for prevention or correction of iron overload.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482913      PMCID: PMC19387          DOI: 10.1073/pnas.95.5.2492

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients.

Authors:  N Borot; M Roth; L Malfroy; C Demangel; J P Vinel; J P Pascal; H Coppin
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

2.  The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

Authors:  J N Feder; Z Tsuchihashi; A Irrinki; V K Lee; F A Mapa; E Morikang; C E Prass; S M Starnes; R K Wolff; S Parkkila; W S Sly; R C Schatzman
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

3.  Heme oxygenase 1 is required for mammalian iron reutilization.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells.

Authors:  A Waheed; S Parkkila; X Y Zhou; S Tomatsu; Z Tsuchihashi; J N Feder; R C Schatzman; R S Britton; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  Identification of a mouse homolog for the human hereditary haemochromatosis candidate gene.

Authors:  K Hashimoto; M Hirai; Y Kurosawa
Journal:  Biochem Biophys Res Commun       Date:  1997-01-03       Impact factor: 3.575

6.  Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.

Authors:  S Parkkila; A Waheed; R S Britton; J N Feder; Z Tsuchihashi; R C Schatzman; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis.

Authors:  G Cairo; S Recalcati; G Montosi; E Castrusini; D Conte; A Pietrangelo
Journal:  Blood       Date:  1997-04-01       Impact factor: 22.113

8.  Mutation analysis in hereditary hemochromatosis.

Authors:  E Beutler; T Gelbart; C West; P Lee; M Adams; R Blackstone; P Pockros; M Kosty; C P Venditti; P D Phatak; N K Seese; K A Chorney; A E Ten Elshof; G S Gerhard; M Chorney
Journal:  Blood Cells Mol Dis       Date:  1996       Impact factor: 3.039

9.  Mutation analysis of the HLA-H gene in Italian hemochromatosis patients.

Authors:  M Carella; L D'Ambrosio; A Totaro; A Grifa; M A Valentino; A Piperno; D Girelli; A Roetto; B Franco; P Gasparini; C Camaschella
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

10.  Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man.

Authors:  M Santos; M W Schilham; L H Rademakers; J J Marx; M de Sousa; H Clevers
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  144 in total

Review 1.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.

Authors:  R E Fleming; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.

Authors:  Jian Wang; Guohua Chen; Kostas Pantopoulos
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 4.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

5.  The origin and spread of the HFE-C282Y haemochromatosis mutation.

Authors:  S Distante; K J H Robson; J Graham-Campbell; A Arnaiz-Villena; P Brissot; Mark Worwood
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

Review 6.  Taming the elephant: Salmonella biology, pathogenesis, and prevention.

Authors:  Helene L Andrews-Polymenis; Andreas J Bäumler; Beth A McCormick; Ferric C Fang
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

7.  Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.

Authors:  A Waheed; S Parkkila; J Saarnio; R E Fleming; X Y Zhou; S Tomatsu; R S Britton; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia.

Authors:  R Kozyraki; J Fyfe; P J Verroust; C Jacobsen; A Dautry-Varsat; J Gburek; T E Willnow; E I Christensen; S K Moestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  HFE polymorphisms affect survival of brain tumor patients.

Authors:  Sang Y Lee; Becky Slagle-Webb; Jonas M Sheehan; Junjia Zhu; Joshua E Muscat; Michael Glantz; James R Connor
Journal:  J Neurooncol       Date:  2014-12-10       Impact factor: 4.130

10.  Of mice and men: the iron age.

Authors:  Sophie Vaulont; Dan-Qing Lou; Lydie Viatte; Axel Kahn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.